Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein…
Tag:
Phase
-
-
Clinical TrialPharma Science & Research
Chikungunya vaccine candidate safe and immunogenic in Phase III
by adminSynopsis : Valneva’s single-shot chikungunya vaccine candidate, VLA1553, offered a very high level of seroprotection…
-
Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based…
-
Global MarketPharma Science & Research
Scancell gains new facilities at The Oxford Science Park
by adminSummary : British biotech company Scancell has expanded its research and development capabilities at one…
-
Summary : The Committee for Medicinal Products for Human Use (CHMP) has provided an initial…
-
Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company…
-
Summary : Moderna is poised to begin Phase III of its pivotal clinical trial for…
-
BayerPharma Science & Research
Bayer delivers on medical innovation fueling transformation of pharma business
by adminSummary : At its annual Pharma Media Day 2022, Bayer presented the latest developments in…
-
ChemIntelligenceGlobal Market
Malvern Panalytical expands pharmaceutical drug development solutions through acquisition of Creoptix
by adminSynopsis : Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma…
-
ChemIntelligenceGlobal Market
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
by adminSynopsis : Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature…
Newer Posts